TD Asset Management
AMRX icon

TD Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

TD Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-267,808
Closed -$777K – 1395
2019
Q3 		$777K Sell
267,808
-172,367
-39% -$601K ﹤0.01% 1104
2019
Q2 		$3.16M Sell
440,175
-42,000
-9% -$429K ﹤0.01% 807
2019
Q1 		$6.83M Buy
482,175
+15,300
+3% +$202K 0.01% 617
2018
Q4 		$6.32M Buy
466,875
+232,043
+99% +$4.18M 0.01% 595
2018
Q3 		$5.21M Buy
+234,832
New +$4.94M 0.01% 716

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return